PHNOM PENH (XINHUA) – A Cambodia’s health spokesperson warned of four-figure numbers of daily COVID-19 cases, urging people to adhere to health protocols.
The country logged 736 new Covid-19 cases yesterday, six of which were imported and all were confirmed to be the Omicron variant of COVID-19, the health ministry said, adding that two new fatalities were registered.
Since the pandemic began in January 2020, the kingdom had recorded a total of 126,489 COVID-19 cases with 120,462 recoveries and 3,017 deaths.
The Health Ministry’s secretary of state and spokeswoman Or Vandine said the Omicron variant has been actively circulating in the country, appealing to members of the public to strictly follow a guideline on three dos and three don’ts and to go for vaccines or booster shots when their turns come.
“The number of daily infections has resurged from a single digit (in mid-December 2021) to two digits and now reached triple digits, so if we all still do not comply with health measures properly, it will hit four digits soon,” she told local media.
The three dos include wearing a face mask, washing hands regularly, and maintaining a physical distance of 1.5 metres, she said, adding that the three don’ts are avoiding confined and enclosed spaces, avoiding crowded spaces, and avoiding touching each other.
The spokeswoman said the vaccine is essential to protect people’s lives, reducing infections, severe illness and death.
World Health Organization (WHO)’s representative to Cambodia Li Ailan said on social media that more people are choosing and experiencing home-based treatment and recovery.
“People who test positive for COVID-19 can usually be cared for safely at home if they are not at high risk for severe disease and they have no or mild symptoms,” she said.
According to the Health Ministry, Cambodia has so far administered two required doses of Covid-19 vaccines to almost 13.8 million people, or 86.3 per cent of its 16 million population, the ministry said.
Most of the vaccines used in the country’s immunisation campaign are China’s Sinovac and
Sinopharm.
